Showing results (241-250 of 324) with videos related to
Sort By:
Pageof 33
BMJ Mental Health|October 9, 2024
Systematic review of interventions for mental health, cognition and psychological well-being in long COVIDLisa D Hawke, Anh T P Nguyen, Wei Wang, et al.JAMA Network Open|September 28, 2023
Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant MedicationBenjamin Schwartzmann, Prabhjot Dhami, Rudolf Uher, et al.Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 15, 2020
Enhancing researcher capacity to engage youth in research: Researchers' engagement experiences, barriers and capacity development prioritiesLisa D Hawke, Karleigh Darnay, Jacqueline Relihan, et al.BMJ Mental Health|January 23, 2025
Minimally important change on the Columbia Impairment Scale and Strengths and Difficulties Questionnaire in youths seeking mental healthcareKarolin R Krause, Alina Lee, Di Shan, et al.Journal of Affective Disorders|February 19, 2026
Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 studyShiny Sachdeva, Victor W Li, Trisha Chakrabarty, et al.BMJ Open|February 8, 2017
Integrated collaborative care teams to enhance service delivery to youth with mental health and substance use challenges: protocol for a pragmatic randomised controlled trialJoanna L Henderson, Amy Cheung, Kristin Cleverley, et al.The Journal of Clinical Psychiatry|November 14, 2019
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled TrialMichael E Thase, Sagar V Parikh, Anthony J Rothschild, et al.BMC Psychiatry|December 29, 2019
Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trialBoadie W Dunlop, Sagar V Parikh, Anthony J Rothschild, et al.The Journal of Clinical Psychiatry|June 20, 2020
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 ReportRudolf Uher, Benicio N Frey, Lena C Quilty, et al.Molecular Psychiatry|June 27, 2022
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysisGustavo C Medeiros, Todd D Gould, William L Prueitt, et al.Pageof 33